Evaluation Study of Hypertension as a Predictor of Efficacy Bevacizumab (BV) in Combination With Chemotherapy (CT) in Metastatic Colorectal Cancer (MCC) and Metastatic Breast Cancer (MBC).
Latest Information Update: 17 Jan 2020
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics; Capecitabine; Fluoropyrimidine derivatives; Irinotecan; Oxaliplatin; Paclitaxel
- Indications Advanced breast cancer; Colorectal cancer; Male breast cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- Acronyms BRECOL
- 14 Dec 2019 Results assessing identification of a specific epigenetic signature (n=113) presented at the 42nd Annual San Antonio Breast Cancer Symposium.
- 03 Dec 2019 Status changed from recruiting to completed.
- 04 Jan 2013 New trial record